Body weight change associated kidney outcomes of sodium-glucose cotransporter new users.
Jimba T, Kaneko H, Azegami T, Suzuki Y, Okada A, Ko T, Fujiu K, Takeda N, Morita H, Hayashi K, Nishiyama A, Node K, Yasunaga H, Takeda N, Nangaku M, Komuro I
https://dom-pubs.onlinelibrary.wiley.com/doi/pdf/10.1111/dom.15808Diabetes Obes Metab. 2024 Jul 28. PMID: 39072974
Comparison of estimated glomerular filtration rate change with sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists among people with diabetes: A propensity-score matching study.
Suzuki Y, Kaneko H, Nagasawa H, Okada A, Fujiu K, Jo T, Takeda N, Morita H, Nishiyama A, Gohda T, Suzuki Y, Node K, Yasunaga H, Nangaku M, Komuro I
https://dom-pubs.onlinelibrary.wiley.com/doi/pdf/10.1111/dom.15561Diabetes Obes Metab. 2024 Jun;26(6):2422-2430. PMID: 38528820
Organelle communication maintains mitochondrial and endosomal homeostasis during podocyte lipotoxicity.
Hasegawa S, Nangaku M, Takenaka Y, Kitayama C, Li Q, Saipidin M, Hong YA, Shang J, Hirabayashi Y, Kubota N, Kadowaki T, Inagi R
https://df6sxcketz7bb.cloudfront.net/manuscripts/182000/182534/jci.insight.182534.v1.pdfJCI Insight. 2024 Aug 8:e182534. PMID: 39115943
